JFrog Ltd
FROG Nasdaq Services-Prepackaged Software Financials FY2018βFY2025
What JFrog Ltd does
No business description yet.
- Legal name
- JFrog Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 13, 2026
- Accession Β· CIK
- 0001193125-26-051382
0001800667
Revenue and margins
JFrog Ltd had $532M of revenue in fiscal 2025, up 24.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $142M in fiscal 2025, 26.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
JFrog Ltd returned β to shareholders in fiscal 2025. The diluted share count rose 5.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably JFrog Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $421M | $443M | $545M | $522M | $704M |
| Current ratio | 2.8x | 2.5x | 2.5x | 2.0x | 2.1x |
| Quick ratio | 2.8x | 2.5x | 2.5x | 2.0x | 2.1x |
| Total assets | $853M | $871M | $973M | $1.1B | $1.3B |
| Total liabilities | $214M | $246M | $293M | $356M | $454M |
| Shareholders' equity | $639M | $625M | $679M | $774M | $887M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 | 3 / 8 | 3 / 8 | 5 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | β | β6.5% | β8.4% | β11.9% | β12.9% | β14.7% | β17.1% | β17.6% |
| Altman Z'' | β | 1.65 | 8.85 | 4.55 | 3.54 | 3.52 | 2.63 | 2.82 |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $63.5M | $105M | $151M | $207M | $280M | $350M | $428M | $532M |
| Gross profit | $52.8M | $84.7M | $122M | $165M | $218M | $273M | $330M | $408M |
| Research and development | $25.9M | $29.7M | $41.1M | $79.6M | $121M | $135M | $161M | $195M |
| Operating income | β$26.9M | β$6.9M | β$14.2M | β$68.4M | β$89.8M | β$75.5M | β$91.1M | β$91.9M |
| Pretax income | β$25.5M | β$3.8M | β$12.1M | β$67.6M | β$84.7M | β$54.5M | β$65.8M | β$66.0M |
| Income tax | $0.5M | $1.6M | β$2.7M | β$3.4M | $5.4M | $6.7M | $3.4M | $5.8M |
| Net income | β$26.0M | β$5.4M | β$9.4M | β$64.2M | β$90.2M | β$61.3M | β$69.2M | β$71.8M |
| Diluted EPS | β$1.00 | β$0.20 | β$0.20 | β$0.68 | β$0.91 | β$0.59 | β$0.63 | β$0.62 |
| Diluted shares | 0.03B | 0.03B | 0.05B | 0.09B | 0.10B | 0.10B | 0.11B | 0.12B |
| Cash flow | ||||||||
| Cash from operations | $8.6M | $10.0M | $29.5M | $27.9M | $21.4M | $74.2M | $111M | $146M |
| Capital expenditure | $2.1M | $1.8M | $3.5M | $4.2M | $4.3M | $2.0M | $3.1M | $3.5M |
| Free cash flow | $6.5M | $8.2M | $25.9M | $23.7M | $17.1M | $72.2M | $108M | $142M |
| Depreciation and amortization | $1.1M | $2.8M | $3.7M | $8.7M | $14.7M | $15.3M | $21.5M | $24.5M |
| Stock-based compensation | $20.2M | $9.4M | $23.9M | $56.9M | $68.7M | $95.2M | $131M | $157M |
| Acquisitions | β | $20.9M | $0.0M | $196M | $0.2M | $0.0M | $157M | $0.0M |
| Balance sheet | ||||||||
| Cash and short-term investments | $178M | $166M | $598M | $421M | $443M | $545M | $522M | $704M |
| Current assets | β | $199M | $653M | $499M | $532M | $646M | $649M | $873M |
| Current liabilities | β | $86.0M | $123M | $175M | $210M | $262M | $318M | $408M |
| Property and equipment, net | β | $3.5M | $5.0M | $6.7M | $8.0M | $6.7M | $5.7M | $5.5M |
| Goodwill | $1.6M | $17.3M | $17.3M | $248M | $248M | $248M | $372M | $372M |
| Intangible assets | β | $5.6M | $4.0M | $48.0M | $37.5M | $25.8M | $60.8M | $39.9M |
| Total assets | β | $238M | $689M | $853M | $871M | $973M | $1.1B | $1.3B |
| Total liabilities | β | $95.6M | $135M | $214M | $246M | $293M | $356M | $454M |
| Preferred stock | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$38.7M | β$33.4M | $554M | $639M | $625M | $679M | $774M | $887M |
| Margins | ||||||||
| Gross margin | 83.1% | 80.9% | 81.1% | 79.8% | 77.8% | 78.0% | 77.1% | 76.8% |
| Operating margin | β42.3% | β6.6% | β9.4% | β33.1% | β32.1% | β21.6% | β21.3% | β17.3% |
| EBITDA margin | β40.5% | β3.9% | β7.0% | β28.8% | β26.8% | β17.2% | β16.3% | β12.7% |
| Net margin | β40.9% | β5.2% | β6.2% | β31.1% | β32.2% | β17.5% | β16.2% | β13.5% |
| FCF margin | 10.2% | 7.8% | 17.2% | 11.5% | 6.1% | 20.6% | 25.2% | 26.8% |
| Returns | ||||||||
| Return on capital employed | β | β4.6% | β2.5% | β10.1% | β13.6% | β10.6% | β11.2% | β9.8% |
| Return on equity | β | β | β3.6% | β10.8% | β14.3% | β9.4% | β9.5% | β8.6% |
| Return on assets | β | β2.3% | β2.0% | β8.3% | β10.5% | β6.6% | β6.6% | β5.8% |
| Return on tangible equity | β | β | β1.8% | β18.7% | β26.6% | β15.1% | β20.3% | β15.1% |
| Growth | ||||||||
| Revenue growth | β | 64.8% | 44.0% | 37.0% | 35.5% | 24.9% | 22.5% | 24.1% |
| FCF growth | β | 26.4% | 216.3% | β8.7% | β27.8% | 322.1% | 49.3% | 32.0% |
| Share count change | β | 3.9% | 71.4% | 103.9% | 4.7% | 4.1% | 6.2% | 5.9% |
| Financial health | ||||||||
| Current ratio | β | 2.3x | 5.3x | 2.8x | 2.5x | 2.5x | 2.0x | 2.1x |
| Quick ratio | β | 2.3x | 5.3x | 2.8x | 2.5x | 2.5x | 2.0x | 2.1x |
| Capital allocation | ||||||||
| Capex / revenue | 3.3% | 1.7% | 2.3% | 2.0% | 1.5% | 0.6% | 0.7% | 0.7% |
| Stock comp / revenue | 31.7% | 8.9% | 15.8% | 27.6% | 24.5% | 27.2% | 30.6% | 29.5% |
| Quality scores | ||||||||
| Piotroski F-score | β | β | 5.0 | 3.0 | 3.0 | 5.0 | 4.0 | 5.0 |
| Altman Z'' | β | 1.7 | 8.8 | 4.6 | 3.5 | 3.5 | 2.6 | 2.8 |
| Accruals ratio | β | β6.5% | β8.4% | β11.9% | β12.9% | β14.7% | β17.1% | β17.6% |
Source: SEC EDGAR XBRL filings (CIK 0001800667). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.